Table 2 Current and estimated study size in the randomised screening design for cervical cancer, Finnish programme during 1999–2008.
From: Alternative technologies in cervical cancer screening: a randomised evaluation trial
|  | 1999–2005 | Overall 1999–2008 | ||
|---|---|---|---|---|
| Â | Invited women | Attended (estimate) | Invited (estimate) | Attended (estimate) |
Randomised | 862,800 | 609,100 | 1,000,000 | 706,000 |
Automation-assisted | 262,900 | 185,300 | 301,900 | 212,800 |
HPV-DNA | 50,800 | 35,600 | 99,600 | 70,000 |
Conventional | 549,100 | 388,200 | 598,500 | 423,200 |